Skip to main content
Scour
Browse
Getting Started
Login
Sign Up
You are offline. Trying to reconnect...
Copied to clipboard
Unable to share or copy to clipboard
Biotech
🧬 Biotech
biotechnology, biopharma, gene therapy, clinical trials
Filter Results
Timeframe
Fresh
Past Hour
Today
This Week
This Month
Feeds to Scour
Subscribed
All
Scoured
472
posts in
6.8
ms
Gene
therapy
approach reduces muscle spasticity after chronic spinal cord injury
🔬
Science Breakthroughs
medicalxpress.com
·
1d
1 day ago
Actions for Gene therapy approach reduces muscle spasticity after chronic spinal cord injury
After Decades of Failure, ‘Undruggable’ Cancers Begin to Give Way
🔬
Science Breakthroughs
singularityhub.com
·
8h
8 hours ago
Actions for After Decades of Failure, ‘Undruggable’ Cancers Begin to Give Way
Cancer
Therapeutics
Startup Earli on China
Biotech
Lead
💊
Drug Development
Content type:
News
bloomberg.com
·
6d
6 days ago
Actions for Cancer Therapeutics Startup Earli on China Biotech Lead
Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid
📩
Substack
Content type:
News
investors.com
·
1d
1 day ago
Actions for Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid
[Correspondence] Single-dose
mRNA
vaccines
against Andes hantavirus
💊
Drug Development
thelancet.com
·
3h
3 hours ago
Actions for [Correspondence] Single-dose mRNA vaccines against Andes hantavirus
Lightning Round: Ondas is just a meme stock, says Jim Cramer
📩
Substack
cnbc.com
·
1d
1 day ago
Actions for Lightning Round: Ondas is just a meme stock, says Jim Cramer
What America Needs From a New FDA Commissioner
💊
Drug Development
realclearpolitics.com
·
5d
5 days ago
Actions for What America Needs From a New FDA Commissioner
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
🔬
Science Breakthroughs
marketwatch.com
·
1d
1 day ago
Actions for GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
Scaling
Bio
009: Benchling's Ashu Singhal and Nicholas Larus-Stone on Building the AI Scientist Inside the Notebook
✍️
AI in Literature
Content type:
News
Content type:
Blog
decodingbio.substack.com
·
11h
11 hours ago
·
Substack
Actions for Scaling Bio 009: Benchling's Ashu Singhal and Nicholas Larus-Stone on Building the AI Scientist Inside the Notebook
Three New Ebola
Vaccines
Are in The Works. Here's The Science Behind Them.
💊
Drug Development
sciencealert.com
·
2d
2 days ago
Actions for Three New Ebola Vaccines Are in The Works. Here's The Science Behind Them.
Charts of the Week: RTO Stalled
📩
Substack
Content type:
News
a16z.news
·
5d
5 days ago
·
Hacker News
Actions for Charts of the Week: RTO Stalled
The State of Biologics Testing Report 2026
💊
Drug Development
genengnews.com
·
13h
13 hours ago
Actions for The State of Biologics Testing Report 2026
First Human Receives Experimental
Therapy
to Reverse
Cellular
Aging
🔬
Science Breakthroughs
gizmodo.com
·
1d
1 day ago
Actions for First Human Receives Experimental Therapy to Reverse Cellular Aging
Bernard Roizman, Virologist Who Demystified Herpes, Dies at 96
🔬
Science Breakthroughs
Content type:
News
nytimes.com
·
6d
6 days ago
Actions for Bernard Roizman, Virologist Who Demystified Herpes, Dies at 96
STAT+: Novo underwhelmed by drug it once fought Pfizer for
💊
Drug Development
statnews.com
·
2d
2 days ago
Actions for STAT+: Novo underwhelmed by drug it once fought Pfizer for
A
CRISPR
activation screen identifies SPART as a pan-orthoflavivirus restriction factor
🔬
Science Breakthroughs
cell.com
·
11h
11 hours ago
Actions for A CRISPR activation screen identifies SPART as a pan-orthoflavivirus restriction factor
Confounder-robust causal discovery and inference in Perturb-seq using proxy and instrumental variables
✍️
AI in Literature
Content type:
Academic
arxiv.org
·
1d
1 day ago
Actions for Confounder-robust causal discovery and inference in Perturb-seq using proxy and instrumental variables
A $435 Million Bet on ‘Reversing Aging’
💊
Drug Development
inc.com
·
4d
4 days ago
Actions for A $435 Million Bet on ‘Reversing Aging’
Report of
gene-edited
human embryos sparks worries about the technology’s future uses
⚖️
Medical Ethics
Content type:
News
scientificamerican.com
·
8h
8 hours ago
Actions for Report of gene-edited human embryos sparks worries about the technology’s future uses
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca
Biotech
: Which Is the Better ETF For Your Portfolio?
💊
Drug Development
fool.com
·
6d
6 days ago
Actions for State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
Sign up or log in to see more results
Sign Up
Login
« Page 2
Log in to enable infinite scrolling
Keyboard Shortcuts
Navigation
Next / previous item
j
/
k
Open post
o
or
Enter
Preview post
v
Post Actions
Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s
Recommendations
Add interest / feed
Enter
Not interested
x
Go to
Home
g
h
Interests
g
i
Feeds
g
f
Likes
g
l
History
g
y
Changelog
g
c
Settings
g
s
Browse
g
b
Search
/
Pagination
Next page
n
Previous page
p
General
Show this help
?
Submit feedback
!
Close modal / unfocus
Esc
Press
?
anytime to show this help